Synaffix B.V., a Lonza company focused on clinical-stage antibody-drug conjugate [...]
Lonza’s Synaffix has signed a licensing agreement with Qurient Therapeutics [...]
Synaffix B.V., a Lonza company focused on clinical-stage antibody-drug conjugate [...]
Lonza’s Synaffix has signed a licensing agreement with Qurient Therapeutics [...]